|
2023
|
Invention
|
Substituted benzoxazole and benzofuran compounds as pde7 inhibitors.
Substituted benzoxazole and... |
|
2022
|
Invention
|
Substituted furanopyrimidine compounds as pde1 inhibitors. Substituted furanopyrimidine chemical ... |
|
|
Invention
|
Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors.
The invention pro... |
|
|
Invention
|
Substituted cyclohexyl compounds as nop inhibitors. Substituted cyclohexyl chemical entities of F... |
|
|
Invention
|
Substituted pyridine and pyrazine compounds as pde4 inhibitors.
The invention provides a chemica... |
|
2021
|
Invention
|
Substituted pyrazolopyrimidinone compounds as pde2 inhibitors. A chemical entity of Formula (I):
... |
|
2020
|
Invention
|
Compounds for therapeutic use.
Chemical entities of Formula (I):
Chemical entities of Formula ... |
|
|
Invention
|
Substituted furanopyrimidine compounds as pde1 inhibitors. a has any of the values described here... |
|
2019
|
Invention
|
Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors. The invention prov... |
|
|
Invention
|
Substituted pyridine and pyrazine compounds as pde4 inhibitors. The invention provides a chemical... |
|
|
Invention
|
Substituted cyclohexyl compounds as nop inhibiiors. b have any of the values described herein, an... |
|
2018
|
Invention
|
Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones. Described herein a... |
|
|
Invention
|
Substituted methyl pyrazolopyrimidinone and methyl imidazopyrazinone compounds as pde1 inhibitors... |
|
|
Invention
|
Substituted benzoxazole and benzofuran compounds as pde7 inhibitors. Substituted benzoxazole and ... |
|
|
Invention
|
Substituted benzoxazole and benzofuran compounds as pde7 inhibitors. mm have any of the values de... |
|
|
Invention
|
Compounds for therapeutic use. Chemical entities of Formula (I):
1 has any of the values describ... |
|
2017
|
Invention
|
Substituted pyrazolopyrimidinone compounds as pde2 inhibitors. A chemical entity of Formula (I), ... |
|
|
Invention
|
Systems and methods for cognitive testing.
Systems, apparatuses, devices, networks, and methods ... |
|
|
Invention
|
Hydroxynorketamine derivatives for the treatment of disorders. Chemical entities of Formula (I): ... |
|
|
Invention
|
Hydroxynorketamine derivatives for the treatment of cns disorders. Chemical entities of Formula (... |
|
|
Invention
|
Substituted naphthyridine and quinoline compounds as mao inhibitors. The invention provides a che... |
|
|
Invention
|
Therapeutic isoxazole compounds. The invention provides a compound of formula I:
1, X, Y, and B ... |
|
2016
|
Invention
|
Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds. Described herein are... |
|
|
Invention
|
Systems and methods for cognitive testing. Methods, systems, apparatuses, and devices for modular... |
|
|
Invention
|
Cognitive test execution and control. Features are provided to dynamically configure a testing sy... |
|
|
Invention
|
Systems and methods for cognitive testing. Methods, systems, and networks for cognitive testing o... |
|
|
P/S
|
SCIENTIFIC RESEARCH AND TECHNOLOGICAL RESEARCH IN THE FIELDS OF THE DEVELOPMENT OF GENE DISCOVERY... |
|
2015
|
Invention
|
Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as pde2 inhibitors. 4, hav... |
|
|
Invention
|
Substituted azetidinyl compounds as glyt1 inhibitors. 4, X, and Y have any of the values describe... |
|
|
Invention
|
Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors. 2, X, Y and Z have... |
|
|
Invention
|
Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo[4,3-c]pyr... |
|
2013
|
Invention
|
Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]py... |
